Search
for
Sort by
Research 271–300 of 1000+
- Dermal papilla regulation of hair growth and pigmentation
- Skin aging: mechanisms, evaluation, and rejuvenation
- Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies
- 915 Dietary grape powder inhibits atopic dermatitis-like skin lesions in NC/Nga mice
- Tissue resident and follicular Treg cell differentiation is regulated by CRAC channels
- Tissue engineering strategies for human hair follicle regeneration: How far from a hairy goal?
- JAK inhibitors in dermatology: The promise of a new drug class
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- JAK inhibition decreases the autoimmune burden in Down syndrome
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- JAK Inhibitors for Treatment of Alopecia Areata
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Simultaneous improvement of alopecia universalis and atopic dermatitis in a patient treated with a JAK inhibitor
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Short-term Efficacy of Tofacitinib, a JAK Inhibitor, in IFIH1-related Aicardi-Goutières Syndrome
- Essential Role of STAT3 Signaling in Hair Follicle Homeostasis
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Pediatric and Adolescent Alopecia Areata Treated with JAK Inhibitors: Balancing Efficacy and Safety Across Clinical Trials
- Integrin signalling regulates YAP/TAZ to control skin homeostasis
- Hedgehog signaling reprograms hair follicle niche fibroblasts to a hyper-activated state
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
- Treatment Response to JAK Inhibitors in Long-standing Alopecia Areata (≥8 Years): A Real-world Observational Study
- Exploring the Complexities of TGF-beta Signaling in Keloids: Beyond the Classical Smad Pathway